Soros Fund Management’s Biolase, Inc. BIOL Stock Holding History

Soros Fund Management’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-2	Closed	-$68K	–	362
2014 Q2	$68K	Buy	+2	New	+$51.1K	﹤0.01%	339

Other funds holding BIOL

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Soros Fund Management's BIOL Position: Q3 2014 in Review

Soros Fund Management sold out of Biolase, Inc. (BIOL) in Q3 2014, closing a stake of 2 shares — an estimated $68K sold.

Soros Fund Management first reported a position in BIOL in Q2 2014 and held it in 1 quarter. The position peaked at $68K in Q2 2014. 35 funds tracked by Wall St. Rank hold BIOL as of Q3 2014.

Soros Fund Management reported no remaining Biolase, Inc. position as of Q3 2014 after selling out during the quarter.
Soros Fund Management sold 2 Biolase, Inc. shares in Q3 2014, an estimated $68K.
Soros Fund Management first reported a position in Biolase, Inc. in Q2 2014 and held it in 1 quarter.
Soros Fund Management's Biolase, Inc. position peaked at $68K in Q2 2014.
35 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2014.

Based on Soros Fund Management's 13F filing for Q3 2014, filed 14 Nov 2014.